|
HSPA9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.12190000026658E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51219999999785E-06 |
| Normal-vs-Stage2 |
2.050500E-02 |
| Normal-vs-Stage3 |
4.635000E-01 |
| Normal-vs-Stage4 |
6.551000E-01 |
| Stage1-vs-Stage2 |
5.786800E-01 |
| Stage1-vs-Stage3 |
5.680200E-02 |
| Stage1-vs-Stage4 |
2.094100E-02 |
| Stage2-vs-Stage3 |
3.147600E-01 |
| Stage2-vs-Stage4 |
8.018000E-02 |
| Stage3-vs-Stage4 |
4.207200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.62910000004002E-06 |
| Normal-vs-AfricanAmerican |
8.31800000000715E-05 |
| Normal-vs-Asian |
9.782800E-01 |
| Caucasian-vs-AfricanAmerican |
8.226800E-01 |
| Caucasian-vs-Asian |
2.066400E-01 |
| AfricanAmerican-vs-Asian |
4.353400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.76340000063769E-08 |
| Normal-vs-Female |
2.039800E-02 |
| Male-vs-Female |
3.616200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.702100E-02 |
| Normal-vs-Extreme_Weight |
3.50740000376604E-08 |
| Normal-vs-Obese |
1.633520E-02 |
| Normal-vs-Extreme_Obese |
9.263300E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.964630E-01 |
| Normal_Weight-vs-Obese |
8.995200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.883600E-01 |
| Extreme_Weight-vs-Obese |
2.229400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.216400E-01 |
| Obese-vs-Extreme_Obese |
8.762800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.916000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.65331999999463E-05 |
| Normal-vs-Age(61-80Yrs) |
1.70785999999978E-05 |
| Normal-vs-Age(81-100Yrs) |
1.011210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.086200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.554400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.483600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.630400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.989600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.037800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.33502147909348E-12 |
| Normal-VS-Type2 PRCC |
4.295600E-01 |
| Normal-VS-KIRP CIMP |
1.661570E-01 |
| Normal-VS-Unclassified PRCC |
2.99690000005182E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.00460000043812E-07 |
| Type1 PRCC-VS-KIRP CIMP |
4.389700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.882980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.902300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.24500000000672E-05 |
| KIRP CIMP-VS-Unclassified PRCC |
2.190600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.931700E-02 |
| Normal-vs-N1 |
6.025600E-01 |
| Normal-vs-N2 |
1.125160E-01 |
| N0-vs-N1 |
2.816200E-01 |
| N0-vs-N2 |
9.954200E-01 |
| N1-vs-N2 |
6.041000E-01 |
|
|
